HIV-1 Co-Receptor Usage Based on V3 Loop Sequence Analysis: Preferential Suppression of CXCR4 Virus Post HAART?

REFERENCES

• Anastos, K., Barrón, Y., Cohen, M., Greenblatt, R., Minkoff, H., Levine, A., Young, M., Gange, S. (2004). The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy. Ann. Intern. Med. 140:256–264.
   PubMed Web of Science ®Google Scholar
• Briggs, D., Tuttle, D., Sleasman, J., Goodenow, M. (2000). Envelope V3 amino acid sequence predicts HIV-1 phenotype (co-receptor usage and tropism for macrophages). AIDS 14:2937–2939.
   PubMed Web of Science ®Google Scholar
• Connor, R. I., Sheridan, K. E., Ceradini D, Choe S, Landau NR. (1997). Change in coreceptor usage correlates with disease progression in HIV-1 infected individuals. J. Exp. Med. 185:621–628.
   PubMed Web of Science ®Google Scholar
• Chen, Y., Shen, C., Wu, H., Caruso, L., Ratner, D., Rodriguez, M., Chen, X., Gupta, P. (2009). Biological properties of HIV-1 subtype B’ isolates from infected Chinese blood donors at different disease stages. Virology 384:161–168.
   Google Scholar
• Cabello, A., Cabral, M., Vera, M.E., Kiefer, R., Azorero, R.M., Eberle, J., Gurtler, L., Von Brunn, A. (1995). Analysis of the V3 loop sequences from 10 HIV type 1-infected AIDS patients from Paraguay. AIDS Res. Human Retroviruses 11:1135–1137.
   PubMedGoogle Scholar
• De Jong, J., De Ronde, A., Keulen, W., Tersmette, M., Goudsmit, J. (1992). Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. J. Virol. 66:6777–6780.
   PubMed Web of Science ®Google Scholar
• Delobel, P., Sandres-Sauné, K., Cazabat, M., Pasquier, C., Marchou, B., Massip, P., Izopet, J. (2005). R5 to X4 switch of the predominant HIV-1 population in cellular reservoirs during effective highly active antiretroviral therapy. J. Acquir. Immune Deficiency Syndromes 38:382–392.
   PubMed Web of Science ®Google Scholar
• Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, K. A., Nagashima, A., Cayanan, C., Maddon, P. J., Koup, R. A., Moore, J. P., Paxton, W. A. (1996). HIV-1 entry into CD+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667–673.
   PubMed Web of Science ®Google Scholar
• Equils, O., Garratty, E., Wei, L., Plaeger, S., Tapia, M., Deville, J., Krogstad, P, Sim, M., Nielsen, K., Bryson, Y. (2000). Recovery of replication competent virus from CD4 T cell reservoirs and change in coreceptor use in Human Immunodeficiency Virus Type 1 infected children responding to highly active antiretroviral therapy. J. Infect. Dis. 182:751–757.
   Google Scholar
• Fouchier, R., Brouwer, M., Broersen, S., Schuitemaker, H. (1995). Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR. J. Clin. Microbiol. 33:906–911.
   Google Scholar
• Galán, I., Jiménez, J., González-Rivera, M., De José, M., Navarro, M., Ramos, J., Mellado, M., Gurbindo, M., Ma Bellón, J., Resino, S. (2004). Virological phenotype switches under salvage therapy with lopinavir-ritonavir in heavily pretreated HIV-1 vertically infected children. AIDS 18:247–255.
   PubMed Web of Science ®Google Scholar
• Garrido, C., Roulet, V., Chueca, N., Poveda, E., Aguilera, A., Skrabal, K., Zahonero, N., Carlos, S., Garcia, F., Faudon, J. (2008). Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes. J. Clin. Microbiol. 46:887–891.
   Google Scholar
• Hartley, O., Klasse, P., Sattentau, Q., Moore, J. (2005). V3: HIV’s switch-hitter. AIDS Res. Human Retroviruses 21:171–189.
   PubMed Web of Science ®Google Scholar
• Hoffman, N. G., Seillier-Moiseiwitsch, F., Ahn, J., Walker, J., Swanstrom, M. (2002).Variability in the human immunodeficiency virus type 1 gp120 Env protein linked to phenotype associated changes in the V3 loop. J. Virol. 76:3852–3864
   Web of Science ®Google Scholar
• Jensen, M., Li, F., van’t Wout, A., Nickle, D., Shriner, D., He, H., McLaughlin, S., Shankarappa, R., Margolick, J., Mullins, J. (2003). Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. J. Virol. 77:13376–13388.
   PubMed Web of Science ®Google Scholar
• Jensen, M., Van’t Wout, A. (2003). Predicting HIV-1 coreceptor usage with sequence analysis. AIDS Rev. 5:104–112.
   Google Scholar
• Johnston, E., Zijenah, L., Mutetwa, S., Kantor, R., Kittinunvorakoon, C., Katzenstein, D. (2003). High frequency of syncytium-inducing and CXCR4-tropic viruses among human immunodeficiency virus type 1 subtype C-infected patients receiving antiretroviral treatment. J. Virol. 77:76–82.
   Google Scholar
• Low, A., Marchant, D., Brumme, C., Brumme, Z., Dong, W., Sing, T., Hogg, R., Montaner, J., Gill, V., Cheung, P. (2008). CD4-dependent characteristics of coreceptor use and HIV type 1 V3 sequence in a large population of therapy-naive individuals. AIDS Res. Human Retroviruses 24:219–228.
   PubMed Web of Science ®Google Scholar
• Liang, H., Shao, Y., Zhang, Z., Xing, H., Lu, C., Wu, H. (2006). The potential relationship between variation of V3 loop in CRF01-AE strains of HIV type 1 from Guangxi and virus biological phenotype. Chin. J. Microbiol. Immunol. 26:1092–1095.
   Google Scholar
• Milch, L. B., Margolin, B., Swanstrom, R. (1993). V3 loop of the immunodeficiency virus type 1 Env protein: interpreting sequence variability. J. Virol. 67:5623–5634.
   Google Scholar
• Mild, M., Kvist, A., Esbjörnsson, J., Karlsson, I., Em, F., Medstrand, P. (2010). Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection. Infect. Genet. Evolut. 10:356–364.
   Google Scholar
• Philpott, S., Weiser, B., Anastos, K., Kitchen, C., Robison, E., Meyer III, W., Sacks, H., Mathur-Wagh, U., Brunner, C., Burger, H. (2001). Preferential suppression of CXCR4-specific strains of HIV-1 by antiviral therapy. J. Clin. Invest. 107:431–438.
   PubMed Web of Science ®Google Scholar
• Pillai, S., Good, B., Richman, D., Corbeil, J. (2003). A new perspective on V3 phenotype prediction. AIDS Res. Human Retroviruses 19:145–149.
   PubMed Web of Science ®Google Scholar
• Polzer, S., Dittmar, M., Schmitz, H., Schreiber, M. (2002). The N-linked glycan g15 within the V3 loop of the HIV-1 external glycoprotein gp120 affects coreceptor usage, cellular tropism, and neutralization. Virology 304:70–80.
   Google Scholar
• Poveda, E., Briz, V., Quiñones-Mateu, M., Soriano, V. (2006). HIV tropism: diagnostic tools and implications for disease progression and treatment with entry inhibitors. AIDS 20:1359–1367.
   PubMed Web of Science ®Google Scholar
• Resch, W., Hoffman, N., Swanstrom, R. (2001). Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks. Virology 288:51–62.
   PubMed Web of Science ®Google Scholar
• Saracino, A., Monno, L., Cibelli, D., Punzi, G., Brindicci, G., Ladisa, N., Tartaglia, A., Lagioia, A., Angarano, G. (2009). Co-receptor switch during HAART is independent of virological success. J. Med. Virol. 2009, 81:2036–2044.
   PubMedGoogle Scholar
• Sing, T., Low, A., Beerenwinkel, N., Sander, O., Cheung, P., Domingues, F., Büch, J., Dumer, M., Kaiser, R., Lengauer, T. (2007). Predicting HIV coreceptor usage on the basis of genetic and clinical covariates. Antivir. Ther. 12:1097–1106.
   Google Scholar
• Soulié, C., Marcelin, A., Ghosn, J., Amellal, B., Assoumou, L, Lambert, S., Duvivier, C., Costagliola, D., Katlama, C., Calvez, V. (2007). HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART. AIDS 21:2243–2245.
   PubMed Web of Science ®Google Scholar
• Skrabal, K., Trouplin, V., Labrosse, B., Obry, V., Damond, F., Hance, A., Clavel, F., Mammano, F. (2003). Impact of antiretroviral treatment on the tropism of HIV-1 plasma virus populations. AIDS 17:809–814.
   PubMed Web of Science ®Google Scholar
• Skrabal, K., Low, A. J., Dong, W., Sing, T., Cheung, P. K., Mammano, F., Harrigan, P. R. (2007). Determining human immunodeficiency virus coreceptor use in a clinical setting: degree of correlation between two phenotypic assays and a bioinformatic model. J. Clin. Microbiol. 45:279–284.
   PubMed Web of Science ®Google Scholar
• Seclen, E., Gonzalez, M., De Mendoza, C., Soriano, V., Poveda, E. (2010). Dynamics of HIV tropism under suppressive antiretroviral therapy: implications for tropism testing in subjects with undetectable viraemia. J. Antimicrob. Chemother. doi: 10.1093/jac/dkq156.
   Google Scholar
• Schuitemaker, H., Koot, M., Kootstra, N., Dercksen, M., De Goede, R., Van Steenwijk, R., Lange, J., Schattenkerk, J., Miedema, F., Tersmette, M. (1992). Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J. Virol. 66:1354–1360.
   PubMed Web of Science ®Google Scholar
• Tamura, K., Dudley, J., Nei, M., Kumar, S. (2007). MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24:1596–1599.
   PubMed Web of Science ®Google Scholar
• Vogel, T., Kurth, R., Norley, S. (1994). The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptides. J. Immunol. 153:1895–1904.
   PubMed Web of Science ®Google Scholar
• Weiser, B., Philpott, S., Klimkait, T., Burger, H., Kitchen, C., Bürgisser, P., Gorgievski, M., Perrin, L., Piffaretti, J., Ledergerber, B. (2008). HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during combination antiretroviral therapy. AIDS 22:469–479.
   PubMed Web of Science ®Google Scholar
• Weber, J., Piontkivska, H., Quiñones-Mateu, M. (2006). HIV type 1 tropism and inhibitors of viral entry: clinical implications. AIDS Rev. 8:60–77.
   PubMed Web of Science ®Google Scholar
• Wong, J. K., Hezareh, M., Gunthard, H. F., Havlir, D. V., Ignacio, C. C., Spina, C. A., Richman, D. D. (1997). Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278:1291–1295.
   PubMed Web of Science ®Google Scholar
• Xiao, L., Rudolph, D., Owen, S., Spira, T., Lal, R. (1998). Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression. AIDS 12:137–143.
   PubMed Web of Science ®Google Scholar
• Xu, S., Huang, X., Xu, H., Zhang, C. (2007). Improved prediction of coreceptor usage and phenotype of HIV-1 based on combined features of V 3 loop sequence using random forest. J. Microbiol. 45:441–446.
   PubMed Web of Science ®Google Scholar
• Zhu, T., Mo, H., Wang, N., Nam, D., Cao, Y., Koup, R., Ho, D. (1993). Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261:1179–1181.
   PubMed Web of Science ®Google Scholar